PAPER Pernod J, Servelle M, Hardel P, Louis P, Haguenauer G, Kermarec J, Duret JC
SEARCH RESULTS
330026 RESULTS
PAPER Hyypp MT, Kangasniemi P
Variation of plasma free tryptophan and CSF 5-HIAA during migraine.
Headache. 1977 Mar 1;17(1):25-7. PubMed: 845024LRRK Watchers’ Eyes Turn to Inflammation, Autophagy, Kinase
CONFERENCE COVERAGE 2013-03-22 Conference Coverage Read a PDF of the entire series. With variants that boost risk for both familial and sporadic Parkinson’s disease, the LRRK2 gene beckons as a prime target for therapy development. But there’s a hitch: No one knows yet how leucine-rich
Blessing or Curse? Peripheral Cytokines in the Brain
CONFERENCE COVERAGE 2013-03-22 Conference Coverage More friendly border than iron curtain, the blood-brain barrier lets all sorts of legitimate travelers pass. Could it also be letting some unsavory characters slip by? The subject of crosstalk between the peripheral circulation and the
PAPER Singh PK, Kotia V, Ghosh D, Mohite GM, Kumar A, Maji SK
Curcumin modulates α-synuclein aggregation and toxicity.
ACS Chem Neurosci. 2013 Mar 20;4(3):393-407. PubMed: 23509976PAPER Nakamura K
α-Synuclein and Mitochondria: Partners in Crime?
Neurotherapeutics. 2013 Mar 20; PubMed: 23512373PAPER Kim E, Lu HC, Zoghbi HY, Song JJ
Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein Ataxin-1 and Capicua.
Genes Dev. 2013 Mar 15;27(6):590-5. PubMed: 23512657PAPER Rabe M, Soragni A, Reynolds NP, Verdes D, Liverani E, Riek R, Seeger S
On-surface aggregation of α-synuclein at nanomolar concentrations results in two distinct growth mechanisms.
ACS Chem Neurosci. 2013 Mar 20;4(3):408-17. PubMed: 23509977PAPER McFarland NR, Okun MS
Movement disorders in 2012: Advancing research towards novel therapeutic approaches.
Nat Rev Neurol. 2013 Feb;9(2):70-1. PubMed: 23296342PAPER Pelech S
Biomarker identification for diagnosis of Alzheimer's disease.
Expert Opin Med Diagn. 2008 May;2(5):577-91. PubMed: 23495745PAPER Zhang HY, Yang DP, Ji HF
Naturally occurring multipotent anti-Alzheimer's agents.
Expert Opin Drug Discov. 2006 Aug;1(3):269-77. PubMed: 23495847PAPER Okamura N, Fodero-Tavoletti MT, Kudo Y, Rowe CC, Furumoto S, Arai H, Masters CL, Yanai K, Villemagne VL
Advances in molecular imaging for the diagnosis of dementia.
Expert Opin Med Diagn. 2009 Nov;3(6):705-16. PubMed: 23496052PAPER Yaari R, Kumar S, Tariot PN
Non-cholinergic drug development for Alzheimer's disease.
Expert Opin Drug Discov. 2008 Jul;3(7):745-60. PubMed: 23496218PAPER Dunlop J, Peri R, Terstappen GC, Bowlby M
Functional screening of α7 nicotinic receptor ligands.
Expert Opin Drug Discov. 2008 Jun;3(6):623-8. PubMed: 23506144PAPER Decker MW, Gopalakrishnan M, Meyer MD
The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions.
Expert Opin Drug Discov. 2008 Sep;3(9):1027-40. PubMed: 23506178Current Filters
No filters selected